January 27, 2015 2:23 PM ET


Company Overview of Sirius Genomics Inc.

Company Overview

Sirius Genomics Inc., a biotechnology company, develops DNA-based companion diagnostics (CDx) and pharmacogenetic tests for acute medical conditions. Its products include CDx for activated protein C to treat severe sepsis, a systemic blood infection. The company was founded in 2001 and is based in Vancouver, Canada.

1125 Howe Street

Suite 603

Vancouver, BC V6Z 2K8


Founded in 2001





Key Executives for Sirius Genomics Inc.

Chief Executive Officer
Age: 45
Founder and Director
Senior Vice President of Clinical and Regulatory Affairs
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Aegera Therapeutics, Inc. Americas
Anandia Laboratories Inc. Americas
Receptor Therapeutics Inc. Americas
Neuropsychiatrie, Découverte & Innovation Inc. Americas
AvidBiologics Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sirius Genomics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.